Prof Georgina Long discusses the long-term outcomes from a Phase II trial which showed that nivolumab/ipilimumab therapy demonstrated durable intracranial responses in patients with melanoma brain metastases. No new adverse events were reported.
Healthcare professionals specialising in skin cancers, including melanoma, now have access to two publications with the most current information relating to skin tumour diagnosis and management. Both publications – the WHO Classification of Skin Tumours, 4th Edition, and Pathology of …
Research that could change clinical practice for high-risk Stage III melanoma patients has been presented at the European Society for Medical Oncology (ESMO) Congress in Munich. The OpACIN-Neo study, led by a team out of the Netherlands with a large …
An international study has found that a single monthly dose of nivolumab can be just as effective as current doses used to treat melanoma and other cancers, and will have a profound impact on clinical care and patient outcomes. The …
New edition of WHO Classification of Skin Tumours released The new WHO Classification of Skin Tumours (including melanoma) has just been released. The 4th edition of WHO Skin Blue Book incorporates the most recent developments in skin tumours, including several …
A world-first study led by The University of Sydney has found that Australians aged 18-40 years who were regular users of sunscreen in childhood reduced their risk of developing melanoma by 40 percent, compared to those who rarely used sunscreen. …
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain. Results from a clinical trial, developed and run by investigators at Melanoma Institute Australia and published in the Lancet Oncology, demonstrate …
The global surgical oncology community is in Chicago this week attending the prestigious Society of Surgical Oncology Annual Cancer Symposium. More than 1,800 health care professionals will be attending the conference, including a number of surgeons and researchers from Melanoma …
Research results from Melanoma Institute Australia (MIA) have been used to help define appropriate excision margins in patients with primary cutaneous melanoma. MIA has been working with Cancer Council Australia since 2016 to develop new evidence-based Australian guidelines for the …